{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:10:40Z","timestamp":1790820640425,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fosfomycin exhibits excellent in vitro activity against multidrug-resistant pathogens, including methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (MRSA). Increasing fosfomycin resistance among clinical MRSA isolates was reported previously, but little is known about the relative abundance of Fosfomycin resistance genes in MRSA isolates circulating in Taiwan.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      All MRSA isolates, collected in 2002 and 2012 by the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program, were used in this study. Susceptibility to various antimicrobial agents, including fosfomycin, was determined by broth microdilution. Genetic determinants of fosfomycin resistance, including\n                      <jats:italic>fosB<\/jats:italic>\n                      carriage and\n                      <jats:italic>murA<\/jats:italic>\n                      ,\n                      <jats:italic>glpT<\/jats:italic>\n                      and\n                      <jats:italic>uhpT<\/jats:italic>\n                      mutations, were investigated using PCR and sequencing of amplicons. Staphylococcal protein A (\n                      <jats:italic>spa<\/jats:italic>\n                      ) typing was also performed to determine the genetic relatedness of MRSA isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 969 MRSA strains, 495 in the year 2002 and 474 in the year 2012, were analyzed. The overall in vitro susceptibility was 8.2% to erythromycin, 18.0% to clindamycin, 29.0% to tetracycline, 44.6% to ciprofloxacin, 57.5% to trimethoprim\/sulfamethoxazole, 86.9% to rifampicin, 92.9% to fosfomycin and 100% to linezolid and vancomycin. A significant increase in the fosfomycin resistance rate was observed from 3.4% in 2002 to 11.0% in 2012. Of 68 fosfomycin-resistant MRSA isolates, several genetic backgrounds probably contributing to fosfomycin resistance were identified. Twelve isolates harbored the\n                      <jats:italic>fosB<\/jats:italic>\n                      gene, and various mutations in\n                      <jats:italic>murA<\/jats:italic>\n                      ,\n                      <jats:italic>uhpT<\/jats:italic>\n                      , and\n                      <jats:italic>glpT<\/jats:italic>\n                      genes were noted in 11, 59, and 66 isolates, respectively. The most prevalent gene mutations were found in the combination of uhpT and glpT genes (58 isolates). The vast majority of the fosfomycin-resistant MRSA isolates belonged to\n                      <jats:italic>spa<\/jats:italic>\n                      type t002.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      An increased fosfomycin resistance rate of MRSA isolates was observed in our present study, mostly due to mutations in the\n                      <jats:italic>glpT<\/jats:italic>\n                      and\n                      <jats:italic>uhpT<\/jats:italic>\n                      genes. Clonal spread probably contributed to the increased fosfomycin resistance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-020-00790-x","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T06:03:15Z","timestamp":1597644195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus"],"prefix":"10.1186","volume":"9","author":[{"given":"Yi-Chien","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pao-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"790_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1126\/science.166.3901.122","volume":"166","author":"D Hendlin","year":"1969","unstructured":"Hendlin D, Stapley EO, Jackson M, Wallick H, Miller AK, Wolf FJ, et al. Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science. 1969;166:122\u20133.","journal-title":"Science."},{"key":"790_CR2","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/S0969-2126(96)00153-0","volume":"4","author":"T Skarzynski","year":"1996","unstructured":"Skarzynski T, Mistry A, Wonacott A, Hutchinson SE, Kelly VA, Duncan K. Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin. Structure. 1996;4:1465\u201374.","journal-title":"Structure."},{"key":"790_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/ja.2013.56","volume":"66","author":"JM Pogue","year":"2013","unstructured":"Pogue JM, Marchaim D, Abreu-Lanfranco O, Sunkara B, Mynatt RP, Zhao JJ, et al. Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10. J Antibiot (Tokyo). 2013;66:625\u20137.","journal-title":"J Antibiot (Tokyo)"},{"key":"790_CR4","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s11255-015-1018-9","volume":"47","author":"YH Cho","year":"2015","unstructured":"Cho YH, Jung SI, Chung HS, Yu HS, Hwang EC, Kim SO, et al. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. Int Urol Nephrol. 2015;47:1059\u201366.","journal-title":"Int Urol Nephrol"},{"key":"790_CR5","first-page":"247","volume":"67","author":"FF Tuon","year":"2013","unstructured":"Tuon FF, Rocha JL, Formighieri MS, Sfair S, Bertoldi MB, Palmeiro JK, et al. Clinical Fosfomycin susceptibility of isolates with blaKPC-2 from Brazil. J Inf Secur. 2013;67:247\u20139.","journal-title":"J Inf Secur"},{"key":"790_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/ppul.22815","volume":"49","author":"EA Champion","year":"2014","unstructured":"Champion EA, Miller MB, Popowitch EB, Hobbs MM, Saiman L, Muhlebach MS, et al. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis. Pediatr Pulmonol. 2014;49:230\u20137.","journal-title":"Pediatr Pulmonol"},{"key":"790_CR7","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1128\/AAC.02099-12","volume":"57","author":"JL Descourouez","year":"2013","unstructured":"Descourouez JL, Jorgenson MR, Wergin JE, Rose WE. Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents. Antimicrob Agents Chemother. 2013;57:1518\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"790_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40360-019-0305-y","volume":"20","author":"YC Lee","year":"2019","unstructured":"Lee YC, Chen PY, Wang JT, Chang SC. A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1\u2009mg\/L against MRSA strains. BMC Pharmacol Toxicol. 2019;20:25.","journal-title":"BMC Pharmacol Toxicol"},{"key":"790_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10096-011-1360-5","volume":"31","author":"G Samonis","year":"2012","unstructured":"Samonis G, Maraki S, Karageorgopoulos DE, Vouloumanou EK, Falagas ME. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis. 2012;31:695\u2013701.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"790_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJM199808203390806","volume":"339","author":"FD Lowy","year":"1998","unstructured":"Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520\u201332.","journal-title":"N Engl J Med"},{"key":"790_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.medmal.2011.09.010","volume":"41","author":"SA Rebiahi","year":"2011","unstructured":"Rebiahi SA, Abdelouahid DE, Rahmoun M, Abdelali S, Azzaoui H. Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (north-West Algeria). Med Mal Infect. 2011;41:646\u201351.","journal-title":"Med Mal Infect"},{"key":"790_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000348572","volume":"91","author":"T Lingscheid","year":"2013","unstructured":"Lingscheid T, Tobudic S, Poeppl W, Mitteregger D, Burgmann H. In vitro activity of doripenem plus fosfomycin against drug-resistant clinical blood isolates. Pharmacology. 2013;91:214\u20138.","journal-title":"Pharmacology."},{"key":"790_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3109\/00365548.2011.616221","volume":"44","author":"A Dinh","year":"2012","unstructured":"Dinh A, Salomon J, Bru JP, Bernard L. Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria. Scand J Infect Dis. 2012;44:182\u20139.","journal-title":"Scand J Infect Dis"},{"key":"790_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijantimicag.2010.09.002","volume":"37","author":"A Florent","year":"2011","unstructured":"Florent A, Chichmanian RM, Cua E, Pulcini C. Adverse events associated with intravenous fosfomycin. Int J Antimicrob Agents. 2011;37:82\u20133.","journal-title":"Int J Antimicrob Agents"},{"key":"790_CR15","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3389\/fmicb.2015.01544","volume":"6","author":"Z Fu","year":"2016","unstructured":"Fu Z, Ma Y, Chen C, Guo Y, Hu F, Liu Y, et al. Prevalence of Fosfomycin resistance and mutations in murA, glpT, and uhpT in methicillin-resistant Staphylococcus aureus strains isolated from blood and cerebrospinal fluid samples. Front Microbiol. 2016;6:1544.","journal-title":"Front Microbiol"},{"key":"790_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1099\/jmm.0.000874","volume":"68","author":"M Aghamali","year":"2019","unstructured":"Aghamali M, Sedighi M, Zahedi Bialvaei A, Mohammadzadeh N, Abbasian S, Ghafouri Z, et al. Fosfomycin: mechanisms and the increasing prevalence of resistance. J Med Microbiol. 2019;68:11\u201325.","journal-title":"J Med Microbiol"},{"key":"790_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijantimicag.2009.11.011","volume":"35","author":"S Takahata","year":"2010","unstructured":"Takahata S, Ida T, Hiraishi T, Sakakibara S, Maebashi K, Terada S, et al. Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli. Int J Antimicrob Agents. 2010;35:333\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"790_CR18","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1128\/AAC.47.9.2850-2858.2003","volume":"47","author":"AI Nilsson","year":"2003","unstructured":"Nilsson AI, Berg OG, Aspevall O, Kahlmeter G, Andersson DI. Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother. 2003;47:2850\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"790_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1128\/AAC.43.4.789","volume":"43","author":"T Horii","year":"1999","unstructured":"Horii T, Kimura T, Sato K, Shibayama K, Ohta M. Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing Escherichia coli O26. Antimicrob Agents Chemother. 1999;43:789\u201393.","journal-title":"Antimicrob Agents Chemother"},{"key":"790_CR20","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1021\/bi963172a","volume":"36","author":"BA Bernat","year":"1997","unstructured":"Bernat BA, Laughlin LT, Armstrong RN. Fosfomycin resistance protein (FosA) is a manganese metalloglutathione transferase related to glyoxalase I and the extradiol dioxygenases. Biochemistry. 1997;36:3050\u20135.","journal-title":"Biochemistry."},{"key":"790_CR21","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/jac\/dks319","volume":"67","author":"SY Lee","year":"2012","unstructured":"Lee SY, Park YJ, Yu JK, Jung S, Kim Y, Jeong SH, et al. Prevalence of acquired fosfomycin resistance among extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother. 2012;67:2843\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"790_CR22","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1021\/bi700625p","volume":"46","author":"KL Fillgrove","year":"2007","unstructured":"Fillgrove KL, Pakhomova S, Schaab MR, Newcomer ME, Armstrong RN. Structure and mechanism of the genomically encoded fosfomycin resistance protein, FosX, from listeria monocytogenes. Biochemistry. 2007;46:8110\u201320.","journal-title":"Biochemistry."},{"key":"790_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jiac.2016.01.010","volume":"22","author":"S Sastry","year":"2016","unstructured":"Sastry S, Doi Y. Fosfomycin: resurgence of an old companion. J Infect Chemother. 2016;22:273\u201380.","journal-title":"J Infect Chemother"},{"key":"790_CR24","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twenty-eighth Informational Supplement M100-S20","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-eighth Informational Supplement M100-S20. Wayne: CLSI; 2018."},{"key":"790_CR25","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1099\/jmm.0.077701-0","volume":"63","author":"C Chen","year":"2014","unstructured":"Chen C, Xu X, Qu T, Yu Y, Ying C, Liu Q, et al. Prevalence of the fosfomycin-resistance determinant, fosB3, in Enterococcus faecium clinical isolates from China. J Med Microbiol. 2014;63:1484\u20139.","journal-title":"J Med Microbiol"},{"key":"790_CR26","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1469-0691.2008.01995.x","volume":"14","author":"AR Larsen","year":"2008","unstructured":"Larsen AR, Stegger M, S\u00f8rum M. Spa typing directly from a mecA, spa and pvl multiplex PCR assay-a cost-effective improvement for methicillin-resistant Staphylococcus aureus surveillance. Clin Microbiol Infect. 2008;14:611\u20134.","journal-title":"Clin Microbiol Infect"},{"key":"790_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ijid.2018.12.002","volume":"79","author":"CY Lee","year":"2019","unstructured":"Lee CY, Fang YP, Chang YF, Wu TH, Yang YY, Huang YC. Comparison of molecular epidemiology of bloodstream methicillin-resistant Staphylococcus aureus isolates between a new and an old hospital in Central Taiwan. Int J Infect Dis. 2019;79:162\u20138.","journal-title":"Int J Infect Dis"},{"key":"790_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1574-6968.1991.tb04580.x","volume":"68","author":"J Etienne","year":"1991","unstructured":"Etienne J, Gerbaud G, Fleurette J, Courvalin P. Characterization of staphylococcal plasmids hybridizing with the fosfomycin resistance gene fosB. FEMS Microbiol Lett. 1991;68:119\u201322.","journal-title":"FEMS Microbiol Lett"},{"key":"790_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.7883\/yoken.JJID.2018.013","volume":"71","author":"D Wu","year":"2018","unstructured":"Wu D, Chen Y, Sun L, Qu T, Wang H, Yu Y. Prevalence of Fosfomycin resistance in methicillin-resistant Staphylococcus aureus isolated from patients in a University Hospital in China from 2013 to 2015. Jpn J Infect Dis. 2018;71:312\u20134.","journal-title":"Jpn J Infect Dis"},{"key":"790_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijantimicag.2018.09.013","volume":"53","author":"ME Falagas","year":"2019","unstructured":"Falagas ME, Athanasaki F, Voulgaris GL, Triarides NA, Vardakas KZ. Resistance to fosfomycin: mechanisms, frequency and clinical consequences. Int J Antimicrob Agents. 2019;53:22\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"790_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fmicb.2018.00163","volume":"9","author":"P Asadollahi","year":"2018","unstructured":"Asadollahi P, Farahani NN, Mirzaii M, Khoramrooz SS, van Belkum A, Asadollahi K, et al. Distribution of the Most prevalent Spa types among clinical isolates of methicillin-resistant and -susceptible Staphylococcus aureus around the world: a review. Front Microbiol. 2018;9:163.","journal-title":"Front Microbiol"},{"key":"790_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2147\/IDR.S192611","volume":"12","author":"Y Liang","year":"2019","unstructured":"Liang Y, Tu C, Tan C, El-Sayed Ahmed MAE, Dai M, Xia Y, et al. Antimicrobial resistance, virulence genes profiling and molecular relatedness of methicillin-resistant Staphylococcus aureus strains isolated from hospitalized patients in Guangdong Province, China. Infect Drug Resist. 2019;12:447\u201359.","journal-title":"Infect Drug Resist"},{"key":"790_CR33","doi-asserted-by":"crossref","unstructured":"Stefanaki C, Ieronymaki A, Matoula T, Caroni C, Polythodoraki E, Chryssou SE, et al. Six-Year Retrospective Review of Hospital Data on Antimicrobial Resistance Profile of Staphylococcus aureus Isolated from Skin Infections from a Single Institution in Greece. Antibiotics (Basel). 2017;6:39.","DOI":"10.3390\/antibiotics6040039"},{"key":"790_CR34","doi-asserted-by":"publisher","first-page":"17916","DOI":"10.1038\/s41598-018-36206-5","volume":"8","author":"H Peng","year":"2018","unstructured":"Peng H, Liu D, Ma Y, Gao W. Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus isolates at a Chinese tertiary hospital, 2012-2017. Sci Rep. 2018;8:17916.","journal-title":"Sci Rep"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-020-00790-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T19:22:39Z","timestamp":1629141759000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-020-00790-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1186\/s13756-020-00790-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.23289\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.23289\/v1","asserted-by":"object"}]},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"8 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out in accordance with the principles stated in the Declaration of Helsinki, and approved by the Ethical Committee of National Taiwan University Hospital (NTUH-IRB No. 201504056RINB). The Review Board approved to waive inform consent due to the retrospective study design and the research posing no more than minimal risk.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}